Patent Assignment
Reel/Frame 071282/0482
Assignment of Assignor's Interest
Recorded: 2025-06-02
Pages: 4
Assignee
SAVIENT PHARMACEUTICALS, INC.
ONE TOWER CENTER BOULEVARD, EAST BRUNSWICK, NEW JERSEY, 08816
Covered Property
(1)
Methods and Kits for Predicting Infusion Reaction Risk and Antibody Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Application:
18/961,687 →
Publication:
US 2025/0231181
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 2, 2025
From: SAVIENT PHARMACEUTICALS, INC.; SAVIENT PHARMA HOLDINGS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 071467/0541 →
Change of Name
Jun 2, 2025
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA USA RHEUMATOLOGY LLC
Reel/Frame 071491/0251 →
Assignment of Assignor's Interest
Jun 2, 2025
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 071491/0279 →
Change of Name
Jun 2, 2025
From: HORIZON PHARMA USA RHEUMATOLOGY LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 071491/0482 →